US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist

2.920
+0.010+0.34%

Close Nov 25 16:00 ET

2.920
0.0000.00%

Post 16:02 ET

224.45MMarket Cap-6636P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

55.74%14.09M

58.54%13.29M

57.42%11.91M

13.43%33.92M

34.19%8.93M

7.61%9.05M

7.19%8.38M

7.66%7.56M

-7.91%29.91M

-19.53%6.66M

Selling and administrative expenses

5.18%2.86M

28.66%3.27M

21.03%3.1M

1.66%10.24M

3.21%2.42M

3.26%2.72M

-6.51%2.54M

7.69%2.56M

6.12%10.07M

11.75%2.34M

-General and administrative expense

5.18%2.86M

28.66%3.27M

21.03%3.1M

1.66%10.24M

3.21%2.42M

3.26%2.72M

-6.51%2.54M

7.69%2.56M

6.12%10.07M

11.75%2.34M

Research and development costs

77.51%11.22M

71.53%10.02M

76.08%8.8M

19.41%23.68M

50.98%6.52M

9.60%6.32M

14.48%5.84M

7.64%5M

-13.71%19.83M

-30.13%4.32M

Operating profit

-55.74%-14.09M

-58.54%-13.29M

-57.42%-11.91M

-13.43%-33.92M

-34.19%-8.93M

-7.61%-9.05M

-7.19%-8.38M

-7.66%-7.56M

7.91%-29.91M

19.53%-6.66M

Net non-operating interest income expense

-30.08%825K

-11.39%934K

0.71%997K

655.11%4.36M

34.40%1.13M

793.94%1.18M

1,154.00%1.05M

432.21%990K

148.41%577K

375.49%843K

Non-operating interest income

-30.18%826K

-22.54%935K

-18.26%998K

172.87%4.75M

1.79%1.14M

179.01%1.18M

518.97%1.21M

30,425.00%1.22M

17,300.00%1.74M

37,133.33%1.12M

Non-operating interest expense

-66.67%1K

-99.35%1K

-99.57%1K

-66.38%391K

-98.54%4K

-98.97%3K

-48.14%153K

-23.51%231K

-3.24%1.16M

-11.33%274K

Other net income (expense)

-107.14%-11K

-103.27%-5K

-100.61%-1K

230.28%469K

-101.04%-3K

154K

212.50%153K

1,600.00%165K

148.46%142K

445.28%289K

Gain on sale of security

----

-279.27%-147K

--0

Other non- operating income (expenses)

-107.14%-11K

-103.27%-5K

-100.61%-1K

62.28%469K

---3K

--154K

--153K

--165K

177.07%289K

----

Income before tax

-72.13%-13.27M

-72.26%-12.36M

-70.26%-10.91M

0.31%-29.1M

-41.23%-7.8M

6.79%-7.71M

10.94%-7.18M

12.63%-6.41M

14.05%-29.19M

35.20%-5.53M

Income tax

-138.46%-31K

73.33%-8K

-14.29%-8K

11.11%-32K

190.00%18K

-85.71%-13K

-650.00%-30K

-40.00%-7K

-71.43%-36K

-233.33%-20K

Net income

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

Net income continuous Operations

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

Minority interest income

Net income attributable to the parent company

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-72.02%-13.24M

-72.88%-12.35M

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

Basic earnings per share

-62.50%-0.13

-71.43%-0.12

-83.33%-0.11

35.56%-0.29

-33.33%-0.08

33.33%-0.08

50.00%-0.07

75.00%-0.06

69.80%-0.45

75.00%-0.06

Diluted earnings per share

-62.50%-0.13

-71.43%-0.12

-83.33%-0.11

35.56%-0.29

-33.33%-0.08

33.33%-0.08

50.00%-0.07

75.00%-0.06

69.80%-0.45

75.00%-0.06

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	55.74%14.09M	58.54%13.29M	57.42%11.91M	13.43%33.92M	34.19%8.93M	7.61%9.05M	7.19%8.38M	7.66%7.56M	-7.91%29.91M	-19.53%6.66M
Selling and administrative expenses	5.18%2.86M	28.66%3.27M	21.03%3.1M	1.66%10.24M	3.21%2.42M	3.26%2.72M	-6.51%2.54M	7.69%2.56M	6.12%10.07M	11.75%2.34M
-General and administrative expense	5.18%2.86M	28.66%3.27M	21.03%3.1M	1.66%10.24M	3.21%2.42M	3.26%2.72M	-6.51%2.54M	7.69%2.56M	6.12%10.07M	11.75%2.34M
Research and development costs	77.51%11.22M	71.53%10.02M	76.08%8.8M	19.41%23.68M	50.98%6.52M	9.60%6.32M	14.48%5.84M	7.64%5M	-13.71%19.83M	-30.13%4.32M
Operating profit	-55.74%-14.09M	-58.54%-13.29M	-57.42%-11.91M	-13.43%-33.92M	-34.19%-8.93M	-7.61%-9.05M	-7.19%-8.38M	-7.66%-7.56M	7.91%-29.91M	19.53%-6.66M
Net non-operating interest income expense	-30.08%825K	-11.39%934K	0.71%997K	655.11%4.36M	34.40%1.13M	793.94%1.18M	1,154.00%1.05M	432.21%990K	148.41%577K	375.49%843K
Non-operating interest income	-30.18%826K	-22.54%935K	-18.26%998K	172.87%4.75M	1.79%1.14M	179.01%1.18M	518.97%1.21M	30,425.00%1.22M	17,300.00%1.74M	37,133.33%1.12M
Non-operating interest expense	-66.67%1K	-99.35%1K	-99.57%1K	-66.38%391K	-98.54%4K	-98.97%3K	-48.14%153K	-23.51%231K	-3.24%1.16M	-11.33%274K
Other net income (expense)	-107.14%-11K	-103.27%-5K	-100.61%-1K	230.28%469K	-101.04%-3K	154K	212.50%153K	1,600.00%165K	148.46%142K	445.28%289K
Gain on sale of security	----	----	----	----	----	----	----	----	-279.27%-147K	--0
Other non- operating income (expenses)	-107.14%-11K	-103.27%-5K	-100.61%-1K	62.28%469K	---3K	--154K	--153K	--165K	177.07%289K	----
Income before tax	-72.13%-13.27M	-72.26%-12.36M	-70.26%-10.91M	0.31%-29.1M	-41.23%-7.8M	6.79%-7.71M	10.94%-7.18M	12.63%-6.41M	14.05%-29.19M	35.20%-5.53M
Income tax	-138.46%-31K	73.33%-8K	-14.29%-8K	11.11%-32K	190.00%18K	-85.71%-13K	-650.00%-30K	-40.00%-7K	-71.43%-36K	-233.33%-20K
Net income	-72.02%-13.24M	-72.88%-12.35M	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M
Net income continuous Operations	-72.02%-13.24M	-72.88%-12.35M	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M
Minority interest income
Net income attributable to the parent company	-72.02%-13.24M	-72.88%-12.35M	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-72.02%-13.24M	-72.88%-12.35M	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M
Basic earnings per share	-62.50%-0.13	-71.43%-0.12	-83.33%-0.11	35.56%-0.29	-33.33%-0.08	33.33%-0.08	50.00%-0.07	75.00%-0.06	69.80%-0.45	75.00%-0.06
Diluted earnings per share	-62.50%-0.13	-71.43%-0.12	-83.33%-0.11	35.56%-0.29	-33.33%-0.08	33.33%-0.08	50.00%-0.07	75.00%-0.06	69.80%-0.45	75.00%-0.06
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data